학술논문

Which is better EGFR-TKI followed by osimertinib: Afatinib or gefitinib/erlotinib?
Document Type
Article
Source
In: Anticancer Research. (Anticancer Research, 2019, 39(7):3923-3929)
Subject
Language
English
ISSN
17917530
02507005